A Prospective Observational Study of Foam Sclerotherapy .

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 6, 2017

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Autosomal Dominant Polycystic KidneyRenal CystAutosomal Dominant Polycystic Liver DiseaseHepatic Cyst
Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04111692 - A Prospective Observational Study of Foam Sclerotherapy . | Biotech Hunter | Biotech Hunter